Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

Loss of heterozygosity analysis defines a 3-cM region of 15q commonly deleted in human malignant mesothelioma

Oncogene volume 20, pages 6245–6249 (2001)Cite this article

Abstract

Previous comparative genomic hybridization and allelic loss analyses demonstrated frequent deletions from 15q11.1–15 in malignant mesothelioma. Recurrent losses of 15q11–22 have also been reported in several other tumor types such as breast and colorectal cancers. To more precisely map the commonly deleted region, we have performed a high density loss of heterozygosity analysis of 46 malignant mesotheliomas, using 26 polymorphic microsatellite markers spanning the entire long arm of chromsome 15. Allelic loss from 15q was observed in 22 of 46 (48%) cases. These analyses have defined a minimally deleted region of ∼3-cM, which was confirmed to reside at 15q15 by fluorescence in situ hybridization analysis with yeast artificial chromosome probes. No tumor suppressor genes have been reported to map to this site. The minimally deleted region identified in this investigation overlaps those observed in other kinds of cancer, and is the smallest site of recurrent 15q loss identified to date in human tumors. The identification of this commonly deleted site implicates a putative tumor suppressor gene(s) at 15q15 involved in diverse forms of human neoplasia.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Altomare DA, Kozak CA, Sonoda G, Testa JR . 1996 Cytogenet. Cell Genet. 74: 248–251

  • Antman KH . 1981 Semin. Oncol. 8: 313–320

  • Antman KH, Li FP, Osteen R, Sugarbaker DJ . 1989 Mesothelioma J.B. Lippincott Co, Philadelphia

    Google Scholar 

  • Attanoos RL, Gibbs AR . 1997 Histopathology 30: 403–418

  • Balsara BR, Bell DW, Sonoda G, De Rienzo A, du Manoir S, Jhanwar SC, Testa JR . 1999 Cancer Res. 59: 450–454

  • Bell DW, Jhanwar SC, Testa JR . 1997 Cancer Res. 57: 4057–4062

  • Bianchi AB, Mitsunaga SI, Cheng JQ, Klein WM, Jhanwar SC, Seizinger B, Kley N, Klein-Szanto AJ, Testa JR . 1995 Proc. Natl. Acad. Sci. USA 92: 10854–10858

  • Bisconti M, Bisetti A, Bidoli P . 2000 Respiration 67: 223–228

  • Bjorkqvist AM, Tammilehto L, Anttila S, Mattson K, Knuutila S . 1997 Br. J. Cancer 75: 523–527

  • Bjorkqvist AM, Wolf M, Nordling S, Tammilehto L, Knuuttila A, Kere J, Mattson K, Knuutila S . 1999 Br. J. Cancer 81: 1111–1115

  • Broman KW, Murray JC, Sheffield VC, White RL, Weber JL . 1998 Am. J. Hum. Genet. 63: 861–869

  • Carbone M, Fisher S, Powers A, Pass HI, Rizzo P . 1999 J. Cell. Physiol. 180: 167–172

  • Cheng JQ, Jhanwar SC, Klein WM, Bell DW, Lee WC, Altomare DA, Nobori T, Olopade OI, Buckler AJ, Testa JR . 1994 Cancer Res. 54: 5547–5551

  • Cheng JQ, Lee WC, Klein MA, Cheng GZ, Jhanwar SC, Testa JR . 1999 Genes Chromosomes Cancer 24: 238–242

  • Collins A, Teague J, Keats BJ, Morton NE . 1996 Genomics 36: 157–162

  • Craighead JE, Mossman BT . 1982 N. Engl. J. Med. 306: 1446–1455

  • De Rienzo A, Jhanwar SC, Testa JR . 2000 Genes Chromosomes Cancer 28: 337–341

  • Dodson MK, Hartmann LC, Cliby WA, DeLacey KA, Keeney GL, Ritland SR, Su JQ, Podratz KC, Jenkins RB . 1993 Cancer Res. 53: 4456–4460

  • Kersemaekers AM, Kenter GG, Hermans J, Fleuren GJ, van de Vijver MJ . 1998 Int. J. Cancer 79: 411–417

  • Knudson AG . 1989 Cancer 63: 1888–1891

  • Lynch HT, Katz D, Markvicka SE . 1985 Cancer Genet. Cytogenet. 15: 25–35

  • Mossman BT, Kamp DW, Weitzman SA . 1996 Cancer Invest. 14: 466–480

  • Olson TM, Michels VV, Thibodeau SN, Tai YS, Keating MT . 1998 Science 280: 750–752

  • Pache JC, Janssen YM, Walsh ES, Quinlan TR, Zanella CL, Low RB, Taatjes DJ, Mossman BT . 1998 Am. J. Pathol. 152: 333–340

  • Park WS, Park JY, Oh RR, Yoo NJ, Lee SH, Shin MS, Lee HK, Han S, Yoon SK, Kim SY, Choi C, Kim PJ, Oh ST, Lee JY . 2000 Cancer Res. 60: 70–73

  • Popescu NC, Chahinian AP, DiPaolo JA . 1988 Cancer Res. 48: 142–147

  • Schmutte C, Tombline G, Rhiem K, Sadoff MM, Schmutzler R, von Deimling A, Fischel R . 1999 Cancer Res. 59: 4564–4569

  • Seemayer TA, Cavenee WK . 1989 Lab. Invest. 60: 585–599

  • Sekido Y, Pass HI, Bader S, Mew DJ, Christman MF, Gazdar AF, Minna JD . 1995 Cancer Res. 55: 1227–1231

  • Shivapurkar N, Virmani AK, Wistuba II, Milchgrub S, Mackay B, Minna JD, Gazdar AF . 1999 Clin. Cancer Res. 5: 17–23

  • Stanton SE, Shin SW, Johnson BE, Meyerson M . 2000 Genes Chromosomes Cancer 27: 323–331

  • Taguchi T, Jhanwar SC, Siegfried JM, Keller SM, Testa JR . 1993 Cancer Res. 53: 4349–4355

  • Tahara H, Smith AP, Gas RD, Cryns VL, Arnold A . 1996 Cancer Res. 56: 599–605

  • Testa JR, Carbone M, Hirvonen A, Khalili K, Krynska B, Linnainmaa K, Pooley FD, Rizzo P, Rusch V, Xiao GH . 1998 Cancer Res. 58: 4505–4509

  • Tomlinson I, Rahman N, Frayling I, Mangion J, Barfoot R, Hamoudi R, Seal S, Northover J, Thomas HJ, Neale K, Hodgson S, Talbot I, Houlston R, Stratton MR . 1999 Gastroenterology 116: 789–795

  • Weinberg R . 1993 Neuron 11: 191–196

  • Wick W, Petersen I, Schmutzler RK, Wolfarth B, Lenartz D, Bierhoff E, Hummerich J, Muller DJ, Stangl AP, Schramm J, Wiestler OD, von Deimling A . 1996 Oncogene 12: 973–978

Download references

Acknowledgements

This investigation was supported by National Cancer Institute Grants CA-45745 and CA-06927, by a gift from the Local #14 Mesothelioma Fund of the International Association of Heat and Frost Insulators & Asbestos Workers in memory of Hank Vaughan and Alice Haas, and by an appropriation from the Commonwealth of Pennsylvania.

Author information

Authors and Affiliations

  1. Human Genetics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, Pennsylvania, USA

    Assunta De Rienzo, Binaifer R Balsara, Sinoula Apostolou & Joseph R Testa

  2. Department of Human Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA

    Suresh C Jhanwar

Authors
  1. Assunta De Rienzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Binaifer R Balsara
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sinoula Apostolou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Suresh C Jhanwar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Joseph R Testa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joseph R Testa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Rienzo, A., Balsara, B., Apostolou, S. et al. Loss of heterozygosity analysis defines a 3-cM region of 15q commonly deleted in human malignant mesothelioma. Oncogene 20, 6245–6249 (2001). https://doi.org/10.1038/sj.onc.1204828

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204828

Keywords

This article is cited by

Search

Advanced search

Quick links